CDKN2A and cancer: To date, the RB1 pathway in human cancers has been reported to be disrupted only by loss of expression of CDKN2A or RB1, as well as by CDK4/CCND1 over- expression [48], even though SWI/SNF is known to be an essential cofactor for RB1 function [16, 17].